These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1481544)

  • 1. [Sequential parenteral and oral therapy with ofloxacin in urogenital infections].
    Presterl E; Bognar H; Winkler S; Thalhammer F; Georgopoulos A; Hoffmann W; Breyer S
    Wien Med Wochenschr; 1992; 142(17):381-5. PubMed ID: 1481544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
    Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
    Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
    Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
    Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of complicated urinary tract infections by ofloxacin].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Negishi T; Horiuchi S; Kaneoya F; Tari K; Satake I; Kojima S
    Hinyokika Kiyo; 1988 Feb; 34(2):394-401. PubMed ID: 3163876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
    Gelfand MS; Simmons BP; Craft RB; Grogan J; Amarshi N
    Am J Med; 1993 Mar; 94(3A):126S-130S. PubMed ID: 8452168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
    Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
    Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Norfloxacin in the treatment of urinary tract infections].
    Joost J
    Wien Klin Wochenschr; 1986 May; 98(11):355-7. PubMed ID: 3524016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S; Ajayi SO; Toki RA
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance of urinary pathogens in female general practice patients.
    Hummers-Pradier E; Koch M; Ohse AM; Heizmann WR; Kochen MM
    Scand J Infect Dis; 2005; 37(4):256-61. PubMed ID: 15871164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
    Takaha M; Ichikawa Y; Sagawa S; Sonoda T; Nakamura T; Kotake T; Miki T; Yano H; Itatani H; Shin T
    Hinyokika Kiyo; 1984 Oct; 30(10):1519-29. PubMed ID: 6098179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiology of urinary tract infection: traditional and emerging pathogens.
    Ronald A
    Dis Mon; 2003 Feb; 49(2):71-82. PubMed ID: 12601338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 2000 Jul; 83(7):771-5. PubMed ID: 10932512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.